Erenumab During Breastfeeding

Abstract

Get full access to this article

View all access options for this article.

References

Goadsby

, Holland

, Martins-Oliveira

, et al. Pathophysiology of migraine: A disorder of sensory processing. Physiol Rev, 2017; 97:553–622.

Skajaa

, Szépligeti

, Xue

et al. Pregnancy, birth, neonatal, and postnatal neurological outcomes after pregnancy with migraine. Headache, 2019; 59:869–879.

Anderson

. Monoclonal antibodies. Breastfeed Med, 2016; 11:100–101.

Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): Erenumab, Last Revision, 2018.

Baker

, Cooper

, Kessler

, et al. Transfer of natalizumab into breast milk in a mother with multiple sclerosis. J Hum Lact, 2015; 31:233–236.

Saito

, Yakuwa

, Takai

, et al. Tocilizumab concentrations in maternal serum and breast milk during breastfeeding and a safety assessment in infants: A case study. Rheumatology (Oxford), 2018; 57:1499–1501.

Nguyen

, Seow

, Maxwell

, et al. The Toronto consensus statements for the management of IBD in pregnancy. Gastroenterology, 2016; 150:734–757.

Flint

, Panchal

, Hurrell

, et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: Standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford), 2016; 55:1693–1697.